NEW YORK, June 27, 2022 /PRNewswire/ —
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Enochian Biosciences, Inc. (NASDAQ: ENOB) resulting from allegations that Enochian BioSciences may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Enochian BioSciences securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=6517 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
WHAT IS THIS ABOUT: On May 25, 2022, during trading hours, the U.S. Department of Justice (DOJ) announced that Serhat Gumrukçu, the inventor and co-founder of Enochian BioSciences, had been arrested and charged in a murder-for-hire conspiracy.
On this news, Enochian BioSciences’s stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, on unusually heavy trading volume, damaging investors
Then, on June 1, 2022, market analyst Hindenburg Research published a report regarding Enochian BioSciences which is entitled “Miracle Cures and Murder For Hire: How A Spoon-Bending Turkish Magician Built A $600…
